Hutch researchers Dr. Irwin Bernstein and Dr. Soheil Meshinchi talked about a drug developed at Fred Hutch. Mylotarg made its debut in 2000, but was taken off the market 10 years later. Now it’s back, and patients with a certain form of acute myeloid leukemia are showing a 35 to 40 percent increase in survival.
In a tribute, Dr. Gary Gilliland talked about working with Dr. Robert W. Day and the last accomplishments the former president made, including moving the Fred Hutch campus to its current location in South Lake Union.
Biologist Dr. Harmit Malik, of the Fred Hutch Basic Sciences Division, was quoted in a story in The Atlantic about Arc, a difficult-to-study gene that looks like a virus and influences learning and memory, apparently by helping neurons share genetic information among themselves.
Commenting on a study about racial and socioeconomic health care disparities among elderly patients with lung cancer, Fred Hutch’s Dr. Veena Shankaran said cultural and community beliefs may play a role in treatment decisions, but “many studies have shown that black patients have less access to cancer care and worse cancer outcomes than whites.”
In a story featuring Bridgette Hempstead, founder of the Cierra Sisters, a support group for black women with breast cancer, Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, said there is a common and false misconception that nothing can be done about a breast cancer diagnosis.